Source Natural Foods & Herbal Supplements Ltd (SOURCENTRL) — shareholding pattern, promoter holding, financials and share price
About Source Natural Foods & Herbal Supplements Ltd (SOURCENTRL)
Source Natural Foods & Herbal Supplements Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as SOURCENTRL and on the BSE under scrip code 531398. Its ISIN is INE679C01027.
Incorporated in 1998, Source Natural Foods and Herbal Supplements Ltd deals in ayurvedic products and green energy segment. [1]
Source Natural Foods & Herbal Supplements Limited is a business engaged in the production and sale of allopathic and ayurvedic formulations.
The company focuses deeply on R&D to diversify its product portfolio, especially in creating herbal and organic nutritional supplements.
Listed peers in Pharmaceuticals: Zenith Drugs Ltd, Veerhealth Care Ltd, Bharat Immunological & Biological Corporation Ltd, Sunil Healthcare Ltd, Vilin Bio Med Ltd, Onyx Biotec Ltd.
Valuation & Returns
10 Jul 2026At ₹111.16 a share on 10 Jul 2026, Source Natural Foods & Herbal Supplements Ltd (SOURCENTRL) was valued at a price-to-earnings ratio of 21.11x against an industry P/E of 36.41x and a price-to-book of 3.2x on a book value of ₹34.73 per share as of Mar 2025. Solomo computes return on equity of 15.16% and return on capital employed of 18.68% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 21.11x
- Industry P/E
- 36.41x
- P/B
- 3.2x
- EPS (TTM)
- ₹5.27
- Book value / share
- ₹34.73
- ROE
- 15.16%
- ROCE
- 18.68%
- ROA
- 9.46%
- Debt / equity
- 0.33x
- Dividend yield
- 0%
- EBITDA margin
- 8.33%
- 52-week range
- ₹96.55 – ₹170
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Source Natural Foods & Herbal Supplements Ltd (SOURCENTRL) reported revenue of ₹70.38 crore, net profit of ₹3.4 crore and earnings per share of ₹5.28. That compares with revenue of ₹44.92 crore and net profit of ₹2.9 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹21.03 crore and net profit ₹1.24 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 21.53 | 19.79 | 27.3 | 44.92 | 70.38 |
| Net profit (₹ cr) | 2.43 | 2.12 | 1.74 | 2.9 | 3.4 |
| EPS (₹) | 3.78 | 3.29 | 2.7 | 4.51 | 5.28 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 15.95% | 24.35% | 27.79% | 64.54% |
| Profit growth | 23.75% | 12.11% | 6.08% | 66.67% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 74.37% of Source Natural Foods & Herbal Supplements Ltd (SOURCENTRL) (unchanged from the previous quarter). Market capitalisation was ₹72 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: GUTTIKONDA VARA LAKSHMI 2.96%, MANMOHAN AGARWAL 1.75%, MULTIPLEX CAPITAL LIMITED 1.13%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 74.37% | - | - | - | 25.63% |
| Mar 2026 | 74.37% | - | - | - | 25.63% |
| Dec 2025 | 74.37% | - | - | - | 25.63% |
| Sep 2025 | 74.37% | - | - | - | 25.63% |
| Jun 2025 | 74.37% | - | - | - | 25.63% |
| Mar 2025 | 74.37% | - | - | - | 25.63% |
| Dec 2024 | 74.37% | - | - | - | 25.63% |
| Sep 2024 | 74.37% | - | - | - | 25.63% |